Modulation of fibrin cofactor activity in plasminogen activation

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 247-260

  Nesheim, Michael ^a   Walker, John ^a   Wang, W E I ^a   Boffa, Michael ^a   Horrevoets, Anton ^a   Bajzar, Laszlo ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Fibrin; Fibrinolysis; Kinetics; Plasmin; Plasminogen; Thrombin activatable fibrinolysis inhibitor; Tissue plasminogen activator

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRIN; LYSINE; PLASMINOGEN; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONFERENCE PAPER; DOWN REGULATION; FIBRIN FORMATION; FIBRINOLYSIS; KINETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY;

EID: 0034974540     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03513.x     Document Type: Conference Paper

References (21)

1. The coagulation cascade: Initiation, maintenance, and regulation
2. Surface-dependent reactions in the propagation phase of blood coagulation
3. Molecular and cellular basis of fibrinolysis
4. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis
5. Fibrinolysis
6. Initiation of the Protein C Pathway
7. Structure function relationships of the thrombin thrombomodulin interaction
8. Purification and characterization of TAFI, a thrombin activatable fibrinolysis inhibitor
9. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
10. Activation and characterization of procarboxypeptidase B from human plasma
11. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen
12. A steady-state template model that describes the kinetics of fibrin-stimulated Glul- and Lys78- plasminogen activation by native tissue type plasminogen activator and variants that lack either the finger or kringle 2 domain
13. The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during the in vitro fibrinolysis
14. The course and prerequisites of Lys-plasminogen formation during fibrinolysis
15. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor
16. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro
17. Production and characterization of recombinant human plasminogen (S741C-Fluorescein): A novel approach to study zymogen activation without generation of active protease
18. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin
19. A kinetic analysis of the tissue plasminogen activator and DSPAα1 cofactor activities of untreated and TAFIa-treated soluble fibrin degredation products of varying size
20. Catalytic domain structure of vampire bat plasminogen activator: A molecular paradigm for proteolysis without activation cleavage
21. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator